An EvoNexus Incubator Company
CB Therapeutics has developed patent-pending technology for the biosynthesis of cannabinoids and other therapeutic molecules found in cannabis. Traditional cannabinoid production using plants leads to high costs, lower purity and quality, and the added health issues due to contaminants such as pesticides and heavy metals. Using our process, the cost of production is lowered to about 1/10th of current production costs, while production time is cut down to less than one week (compared to 3-4 months). Lastly, our platform gives us the ability to produce any of the 105 cannabinoids in cannabis, most which are too rare for commercial production.